LifePoint Health, Inc. (NASDAQ:LPNT) – Research analysts at KeyCorp lowered their Q3 2017 EPS estimates for LifePoint Health in a report released on Thursday. KeyCorp analyst J. Gurda now expects that the company will earn $0.92 per share for the quarter, down from their prior forecast of $0.99. KeyCorp also issued estimates for LifePoint Health’s Q4 2017 earnings at $1.17 EPS and FY2017 earnings at $4.11 EPS.
Several other analysts also recently weighed in on LPNT. Barclays PLC lifted their target price on LifePoint Health from $58.00 to $60.00 and gave the company an “equal weight” rating in a research note on Monday, May 1st. Morgan Stanley started coverage on LifePoint Health in a research note on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 target price on the stock. Leerink Swann raised LifePoint Health from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $73.00 to $74.00 in a research note on Tuesday, June 6th. BidaskClub raised LifePoint Health from a “sell” rating to a “hold” rating in a research note on Wednesday, June 14th. Finally, Zacks Investment Research raised LifePoint Health from a “hold” rating to a “buy” rating and set a $75.00 target price on the stock in a research note on Tuesday, July 4th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $66.18.
LifePoint Health (LPNT) opened at 58.65 on Monday. The stock’s 50 day moving average price is $64.19 and its 200 day moving average price is $62.87. LifePoint Health has a 12-month low of $50.60 and a 12-month high of $70.95. The stock has a market cap of $2.35 billion, a price-to-earnings ratio of 13.13 and a beta of 0.86.
LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings results on Tuesday, August 1st. The company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.90 by $0.06. LifePoint Health had a return on equity of 7.40% and a net margin of 2.61%. The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the firm earned $0.69 EPS. The company’s quarterly revenue was up .2% compared to the same quarter last year.
Several hedge funds and other institutional investors have recently modified their holdings of LPNT. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of LifePoint Health by 10.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock worth $113,000 after buying an additional 164 shares in the last quarter. LS Investment Advisors LLC increased its position in shares of LifePoint Health by 43.7% in the second quarter. LS Investment Advisors LLC now owns 1,785 shares of the company’s stock worth $120,000 after buying an additional 543 shares in the last quarter. US Bancorp DE increased its position in shares of LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock worth $127,000 after buying an additional 30 shares in the last quarter. Bank of Montreal Can increased its position in shares of LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock worth $128,000 after buying an additional 306 shares in the last quarter. Finally, Teacher Retirement System of Texas acquired a new position in shares of LifePoint Health during the first quarter worth $210,000. Institutional investors and hedge funds own 99.27% of the company’s stock.
In other news, Chairman William F. Carpenter III sold 17,653 shares of LifePoint Health stock in a transaction on Monday, July 17th. The stock was sold at an average price of $65.06, for a total transaction of $1,148,504.18. Following the transaction, the chairman now owns 439,841 shares in the company, valued at $28,616,055.46. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard H. Evans sold 2,000 shares of LifePoint Health stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $62.88, for a total value of $125,760.00. Following the transaction, the director now owns 17,718 shares in the company, valued at approximately $1,114,107.84. The disclosure for this sale can be found here. Insiders sold a total of 102,000 shares of company stock worth $6,556,824 over the last 90 days. Insiders own 7.28% of the company’s stock.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
What are top analysts saying about LifePoint Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LifePoint Health Inc. and related companies.